Amphera Gears Up To Evaluate Dendritic Cells For Pleural Mesothelioma
Executive Summary
Dutch biotech Amphera has progressed into late-stage clinical studies with dendritic cells activated with an allogeneic lysate of tumor cell lines; the dendritic cells are expected to have a therapeutic effect in patients with mesothelioma, a tumor with few treatment options.